120 related articles for article (PubMed ID: 9492078)
1. The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats.
Yamamoto M; Fisher JE; Gentile M; Seedor JG; Leu CT; Rodan SB; Rodan GA
Endocrinology; 1998 Mar; 139(3):1411-9. PubMed ID: 9492078
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat.
Lark MW; Stroup GB; Dodds RA; Kapadia R; Hoffman SJ; Hwang SM; James IE; Lechowska B; Liang X; Rieman DJ; Salyers KL; Ward K; Smith BR; Miller WH; Huffman WF; Gowen M
J Bone Miner Res; 2001 Feb; 16(2):319-27. PubMed ID: 11204432
[TBL] [Abstract][Full Text] [Related]
3. Histomorphometric evidence for echistatin inhibition of bone resorption in mice with secondary hyperparathyroidism.
Masarachia P; Yamamoto M; Leu CT; Rodan G; Duong L
Endocrinology; 1998 Mar; 139(3):1401-10. PubMed ID: 9492077
[TBL] [Abstract][Full Text] [Related]
4. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
Mercer B; Markland F; Minkin C
J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
[TBL] [Abstract][Full Text] [Related]
5. Echistatin inhibits the migration of murine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells.
Nakamura I; Tanaka H; Rodan GA; Duong LT
Endocrinology; 1998 Dec; 139(12):5182-93. PubMed ID: 9832459
[TBL] [Abstract][Full Text] [Related]
6. Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone.
Nakamura I; Pilkington MF; Lakkakorpi PT; Lipfert L; Sims SM; Dixon SJ; Rodan GA; Duong LT
J Cell Sci; 1999 Nov; 112 ( Pt 22)():3985-93. PubMed ID: 10547359
[TBL] [Abstract][Full Text] [Related]
7. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
8. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
Lark MW; Stroup GB; Hwang SM; James IE; Rieman DJ; Drake FH; Bradbeer JN; Mathur A; Erhard KF; Newlander KA; Ross ST; Salyers KL; Smith BR; Miller WH; Huffman WF; Gowen M
J Pharmacol Exp Ther; 1999 Nov; 291(2):612-7. PubMed ID: 10525079
[TBL] [Abstract][Full Text] [Related]
9. A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.
Engleman VW; Nickols GA; Ross FP; Horton MA; Griggs DW; Settle SL; Ruminski PG; Teitelbaum SL
J Clin Invest; 1997 May; 99(9):2284-92. PubMed ID: 9151803
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats.
Cui L; Wu T; Liu YY; Deng YF; Ai CM; Chen HQ
Acta Pharmacol Sin; 2004 May; 25(5):678-84. PubMed ID: 15132837
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein.
Fisher JE; Caulfield MP; Sato M; Quartuccio HA; Gould RJ; Garsky VM; Rodan GA; Rosenblatt M
Endocrinology; 1993 Mar; 132(3):1411-3. PubMed ID: 8440195
[TBL] [Abstract][Full Text] [Related]
12. Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis.
Dresner-Pollak R; Rosenblatt M
J Cell Biochem; 1994 Nov; 56(3):323-30. PubMed ID: 7876325
[TBL] [Abstract][Full Text] [Related]
13. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
Iwaniec UT; Yuan D; Power RA; Wronski TJ
J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
[TBL] [Abstract][Full Text] [Related]
14. Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site.
Marcinkiewicz C; Vijay-Kumar S; McLane MA; Niewiarowski S
Blood; 1997 Aug; 90(4):1565-75. PubMed ID: 9269775
[TBL] [Abstract][Full Text] [Related]
15. Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation.
van der Pluijm G; Mouthaan H; Baas C; de Groot H; Papapoulos S; Löwik C
J Bone Miner Res; 1994 Jul; 9(7):1021-8. PubMed ID: 7942148
[TBL] [Abstract][Full Text] [Related]
16. Integrin function in osteoclasts.
Rodan SB; Rodan GA
J Endocrinol; 1997 Sep; 154 Suppl():S47-56. PubMed ID: 9379137
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin provides complete protection against cancellous bone loss in the femoral neck of ovariectomized rats.
Shen Y; Li M; Wronski TJ
Calcif Tissue Int; 1997 May; 60(5):457-61. PubMed ID: 9115164
[TBL] [Abstract][Full Text] [Related]
18. Echistatin is a potent inhibitor of bone resorption in culture.
Sato M; Sardana MK; Grasser WA; Garsky VM; Murray JM; Gould RJ
J Cell Biol; 1990 Oct; 111(4):1713-23. PubMed ID: 2211834
[TBL] [Abstract][Full Text] [Related]
19. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
[TBL] [Abstract][Full Text] [Related]
20. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD
J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]